Effects of Empagliflozin on vascular and skeletal mineralization in Hyperlipidemic mice

By sjmartinez • May 2, 2024

Kalanski S, Pradhan S, Hon A, Xia Y, Safvati N, Rivera JC, Lu M, Demer LL, Tintut Y. Effects of Empagliflozin on vascular and skeletal mineralization in Hyperlipidemic mice. Vascul Pharmacol. 2024 Apr 29:107376. doi: 10.1016/j.vph.2024.107376. Epub ahead of print. PMID: 38692418.

Tags: Cardiology/Epi, empagliflozin, hyperlipidemia, Publications, SGLT2

Cardiovascular Risks and Outcomes Among Chinese American Immigrants: Insights From the Multi-Ethnic Study of Atherosclerosis

Cai X, White Q, Wang DR, DeFilippi CR, Bertoni AG, Wu CO, Liu K, Lima JAC, Budoff MJ, Fonarow GC, Watson KE, McClelland RL, Yang[...]

Rural Hospital Performance in Guideline-Recommended Ischemic Stroke Thrombolysis, Secondary Prevention, and Outcomes

Man S, Bruckman D, Uchino K, Chen BY, Dalton JE, Fonarow GC. Rural Hospital Performance in Guideline-Recommended Ischemic Stroke Thrombolysis, Secondary Prevention, and Outcomes. Stroke.[...]

Diabetes, Functional Status, and Mortality in Chronic Heart Failure

Noumegni SR, Kaze AD, Bertoni AG, Fonarow GC, Echouffo-Tcheugui JB. Diabetes, Functional Status, and Mortality in Chronic Heart Failure. Diabetes Care. 2024 Sep 4:dc241586. doi:[...]